ପ୍ରେଟୋମାନିଡ

ପ୍ରେଟୋମାନିଡ
Clinical data
Trade names	Dovprela
Synonyms	Pretomanid FGK, PA-824
AHFS/Drugs.com	monograph
MedlinePlus	a619056
data	US DailyMed: Pretomanid;
Routes of; administration	By mouth
Legal status
Legal status	US: ℞-only ; EU: Rx-only ;
Identifiers
	IUPAC name (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;
Chemical and physical data
Formula	C14H12F3N3O5
Molar mass	୩୫୯.୨୬ g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [O-][N+](=O)c1cn2C[C@@H](COc2n1)OCc3ccc(OC(F)(F)F)cc3;
	InChI InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1 ; Key:ZLHZLMOSPGACSZ-NSHDSACASA-N ;

ଇଂରାଜୀ ଲିଙ୍କ

https://or.wikipedia.org/wiki/Pretomanid

ପ୍ରେଟୋମାନିଡ (ଇଂରାଜୀ ଭାଷାରେ Pretomanid), ଡୋଭପ୍ରେଲା ଏହାର ଏକ ବେପାର ନାମ, ହେଉଛି ଏକ ଆଣ୍ଟିବାୟୋଟିକ ଯାହା ବହୁ ଔଷଧ ପ୍ରତିରୋଧ ପ୍ରଭାବିତ ଯକ୍ଷ୍ମା ଫୁସଫୁସ ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।^[୩] ଏହା ସାଧାରଣତଃ ବେଡାକୁଇଲିନ୍ ଏବଂ ଲିନେଜୋଲିଡ ସହିତ ଏକତ୍ର ଦିଆଯାଏ ।^[୧] ଏହା ପାଟିରେ ଦିଆଯାଏ ।^[୧]

ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ସ୍ନାୟୁ କ୍ଷତି, ବ୍ରଣ, ବାନ୍ତି, ମୁଣ୍ଡବିନ୍ଧା, କମ୍ ରକ୍ତ ଶର୍କରା, ତରଲ ଝାଡ଼ା ଏବଂ ଯକୃତ ପ୍ରଦାହ ହୋଇପାରେ ।^[୩] ଅନ୍ୟ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଅସ୍ଥି ମଜ୍ଜା ଦମନ, ଅପ୍ଟିକ୍ ନ୍ୟୁରୋପାଥି (optic neuropathy) ଏବଂ କ୍ୟୁଟି (QT) ବିସ୍ତାର ହୋଇପାରେ । ^[୪] ଗର୍ଭାବସ୍ଥାରେ ସୁରକ୍ଷା ଅସ୍ପଷ୍ଟ ଅଟେ ।^[୫] ଏହା ନାଇଟ୍ରୋଇମିଡାଜୋଲ ଶ୍ରେଣୀର ଏକ ଔଷଧ ।^[୬]

୨୦୧୯ ମସିହାରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏବଂ ୨୦୨୦ରେ ୟୁରୋପରେ ଚିକିତ୍ସା କ୍ଷେତ୍ରରେ ବ୍ୟବହାର ପାଇଁ ପ୍ରେଟୋମାନିଡ ଅନୁମୋଦିତ ହୋଇଥିଲା ।^[୩] ^[୧] ବିଶ୍ୱ ସ୍ୱାସ୍ଥ୍ୟ ସଂଗଠନର ଜରୁରୀ ଔଷଧ ତାଲିକାରେ ଏହାର ନାମ ଅଛି ।^[୭] ବିକାଶଶୀଳ ଦେଶରେ ୨୦୧୯ରେ ୬ ମାସର ଚିକିତ୍ସା ପାଇଁ ଏହାର ମୂଲ୍ୟ ୩୬୪ ଡଲାର ଥିଲା ।^[୮] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହି ପରିମାଣର ୨୦୨୧ ସୁଦ୍ଧା ପ୍ରାୟ ୩,୮୦୦ ଡଲାର ଅଟେ ।^[୯] ଏହାକୁ ଟିବି ଆଲିଆନ୍ସଦ୍ୱାରା ବିକଶିତ କରାଯାଇଥିଲା ।^[୬] ^[୩]

ଆଧାର

↑ ^୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Pretomanid FGK EPAR". European Medicines Agency (EMA). 24 March 2020. Archived from the original on 20 October 2020. Retrieved 25 September 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
↑ "Pretomanid tablet". DailyMed. 15 September 2019. Archived from the original on 21 October 2021. Retrieved 25 September 2020.
↑ ^୩.୦ ^୩.୧ ^୩.୨ ^୩.୩ "FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs" (Press release). 14 August 2019. Archived from the original on 19 August 2019. Retrieved 28 August 2019.
↑ "Pretomanid Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Retrieved 29 October 2021.
↑ "Pretomanid Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Retrieved 29 October 2021.
↑ ^୬.୦ ^୬.୧ "Our Pipeline". TB Alliance. Archived from the original on 7 April 2019. Retrieved 18 April 2019.
↑ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
↑ "Price announced for new lifesaving TB drug pretomanid still too high". Médecins Sans Frontières Access Campaign (in ଇଂରାଜୀ). Archived from the original on 3 March 2021. Retrieved 29 October 2021.
↑ "Pretomanid Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 19 January 2021. Retrieved 29 October 2021.

[EPAR2021-1] ୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Pretomanid FGK EPAR". European Medicines Agency (EMA). 24 March 2020. Archived from the original on 20 October 2020. Retrieved 25 September 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

[Pretomanid_FDA_label-2] "Pretomanid tablet". DailyMed. 15 September 2019. Archived from the original on 21 October 2021. Retrieved 25 September 2020.

[FDA2019-3] ୩.୦ ^୩.୧ ^୩.୨ ^୩.୩ "FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs" (Press release). 14 August 2019. Archived from the original on 19 August 2019. Retrieved 28 August 2019.

[AHFS2021-4] "Pretomanid Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Retrieved 29 October 2021.

[5] "Pretomanid Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Retrieved 29 October 2021.

[Tb2021-6] ୬.୦ ^୬.୧ "Our Pipeline". TB Alliance. Archived from the original on 7 April 2019. Retrieved 18 April 2019.

[WHO23rd-7] World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.

[8] "Price announced for new lifesaving TB drug pretomanid still too high". Médecins Sans Frontières Access Campaign (in ଇଂରାଜୀ). Archived from the original on 3 March 2021. Retrieved 29 October 2021.

[9] "Pretomanid Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 19 January 2021. Retrieved 29 October 2021.

[୨]

[୧]

[୩]

[୪]

[୫]

[୬]

[୭]

[୮]

[୯]